Phase 3 Chronic Hepatitis Clinical Trials

8 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 18 of 8 trials

Recruiting
Phase 2Phase 3

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

Chronic Hepatitis D
Mirum Pharmaceuticals, Inc.120 enrolled22 locationsNCT07454837
Recruiting
Phase 3

A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.300 enrolled1 locationNCT07343778
Recruiting
Phase 3

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.172 enrolled44 locationsNCT07200908
Recruiting
Phase 3

A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.80 enrolled27 locationsNCT07298330
Recruiting
Phase 3

A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B

Chronic Hepatitis BAzvudine
Zhigang Ren120 enrolled1 locationNCT07307586
Active
Phase 3

A Study to Evaluate Tobevibart+Elebsiran in Chronic Hepatitis Delta Virus (HDV) Infection (ECLIPSE 1)

Chronic Hepatitis Delta Virus (HDV) Infection
Vir Biotechnology, Inc.120 enrolled10 locationsACTRN12625000416493
Not Yet Recruiting
Phase 3

Tenofovir versus Adefovir for the treatment of HBeAg negative chronic hepatitis B

HBeAg negative Chronic Hepatitis B
Gilead Sciences Inc300 enrolled1 locationACTRN12605000029695
Not Yet Recruiting
Phase 3

Tenofovir versus Adefovir for the treatment of HBeAg positive chronic hepatitis B

HBeAg positive chronic hepatitis B
Gilead Sciences Inc240 enrolled1 locationACTRN12605000028606